Complete routine immunisation schedule from 1 January 2025
Updated 3 June 2025
For vaccine supply information for the routine immunisation schedule please visit and check Vaccine update for all other vaccine supply information.
Complete routine immunisation schedule from 1 January 2025
When | Diseases protected against | Vaccine given | Trade name | Usual site [footnote 1] |
8 weeks old | Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B | DTaP/IPV/Hib/HepB | Infanrix hexa or Vaxelis | Thigh |
Ìý | Meningococcal group B (MenB) | MenB | Bexsero | Left thigh |
Ìý | Rotavirus gastroenteritis | Rotavirus [footnote 2] | Rotarix [footnote 2] | By mouth |
12 weeks old | Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B | DTaP/IPV/Hib/HepB | Infanrix hexa or Vaxelis | Thigh |
Ìý | Pneumococcal (13 serotypes) | Pneumococcal conjugate vaccine (PCV) | Prevenar 13 | Thigh |
Ìý | Rotavirus | Rotavirus [footnote 2] | Rotarix [footnote 2] | By mouth |
16 weeks old | Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B | DTaP/IPV/Hib/HepB | Infanrix hexa or Vaxelis | Thigh |
Ìý | MenB | MenB | Bexsero | Thigh |
One year old (on or after the child’s first birthday) | Hib and Meningococcal group C (MenC) | Hib/MenC | Menitorix | Upper arm or thigh |
Ìý | Pneumococcal | PCV booster | Prevenar 13 | Upper arm or thigh |
Ìý | Measles, mumps and rubella (German measles) | MMR | MMRvaxPro [footnote 3] or Priorix | Upper arm or thigh |
Ìý | MenB | MenB booster | Bexsero | Left thigh |
Eligible paediatric age group [footnote 4] | Influenza (each year from September) | Live attenuated influenza vaccine LAIV [footnote 3], [footnote 5] | Fluenz Tetra [footnote 3], [footnote 5] | Both nostrils |
3 years 4 months old or soon after | Diphtheria, tetanus, pertussis and polio | dTaP/IPV | REPEVAX | Upper arm |
Ìý | Measles, mumps and rubella | MMR (check first dose given) | MMRvaxPro [footnote 3] or Priorix | Upper arm |
Boys and girls aged 12 to 13 years | Cancers and genital warts caused by specific human papillomavirus (HPV) types | HPV [footnote 6] | Gardasil 9 | Upper arm |
14 years old (school Year 9) | Tetanus, diphtheria and polio | Td/IPV (check MMR status) | REVAXIS | Upper arm |
Ìý | Meningococcal groups A, C, W and Y | MenACWY | MenQuadfi | Upper arm |
65 years old | Pneumococcal (23 serotypes) | Pneumococcal polysaccharide vaccine (PPV23) | Pneumovax 23 | Upper arm |
65 years of age and older | Influenza (each year from September) | Inactivated influenza vaccine | Multiple | Upper arm |
65 from September 2023 [footnote 7] | Shingles | Shingles vaccine | Shingrix | Upper arm |
70 to 79 years of age (plus eligible age groups and severely immunosuppressed) [footnote 7] | Shingles | Shingles vaccine | Zostavax [footnote 3], [footnote 7] (or Shingrix if Zostavax contraindicated) | Upper arm |
75 years old | Respiratory syncytial virus (RSV) | RSV vaccine | Abrysvo | Upper arm |
Selective immunisation programmes
Target group | Age and schedule | Disease | Vaccines required | |
---|---|---|---|---|
Babies born to hepatitis B infected mothers | At birth, 4 weeks and 12 months old [footnote 8], [footnote 9] | Hepatitis B | Hepatitis B (Engerix B/HBvaxPRO) | Ìý |
Infants in areas of the country with tuberculosis (TB) incidence >= 40/100,000 | Around 28 days old [footnote 10] | Tuberculosis | BCG | Ìý |
Infants with a parent or grandparent born in a high incidence country [footnote 11] | Around 28 days old [footnote 10] | Tuberculosis | BCG | Ìý |
Children in a clinical risk group | From 6 months to 17 years of age | Influenza | LAIV or inactivated flu vaccine if contraindicated to LAIV or under 2 years of age | Ìý |
Pregnant women | At any stage of pregnancy during flu season | Influenza | Inactivated flu vaccine | Ìý |
Ìý | From 16 weeks gestation [footnote 12] | Pertussis | Tdap (ADACEL) | Ìý |
Ìý | From 28 weeks gestation | RSV | RSV vaccine (Abrysvo) | Ìý |
Additional vaccines for individuals with underlying medical conditions
Medical condition | Diseases protected against | Vaccines required [footnote 13] |
Asplenia or splenic dysfunction (including due to sickle cell and coeliac disease) | Meningococcal groups A, B, C, W and Y |
MenACWY MenB |
Ìý | Pneumococcal |
PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age) |
Ìý | Influenza | Annual flu vaccine |
Cochlear implants | Pneumococcal |
PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age) |
Chronic respiratory and heart conditions (such as severe asthma, chronic pulmonary disease, and heart failure) | Pneumococcal |
PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age) |
Ìý | Influenza | Annual flu vaccine |
Chronic neurological conditions (such as Parkinson’s or motor neurone disease, or learning disability) | Pneumococcal (only if the individual is also at increased risk of aspiration) |
PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age) |
Ìý | Influenza | Annual flu vaccine |
Diabetes | Pneumococcal |
PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age) |
Ìý | Influenza | Annual flu vaccine |
Chronic kidney disease (CKD) (including haemodialysis) | Pneumococcal (stage 4 and 5 CKD) |
PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age) |
Ìý | Influenza (stage 3, 4 and 5 CKD) | Annual flu vaccine |
Ìý | Hepatitis B (stage 4 and 5 CKD) | Hepatitis B |
Chronic liver conditions | Pneumococcal |
PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age) |
Ìý | Influenza | Annual flu vaccine |
Ìý | Hepatitis A | Hepatitis A |
Ìý | Hepatitis B | Hepatitis B |
Haemophilia | Hepatitis A | Hepatitis A |
Ìý | Hepatitis B | Hepatitis B |
Immunosuppression due to disease or treatment [footnote 15] | Pneumococcal |
PCV13 (up to 10 years of age) [footnote 14], [footnote 16] PPV23 (from 2 years of age) |
Ìý | Shingles vaccine | Shingrix – over 50 years of age [footnote 7] |
Ìý | Influenza | Annual flu vaccine |
Complement disorders (including those receiving complement inhibitor therapy) | Meningococcal groups A, B, C, W and Y |
MenACWY MenB |
Ìý | Pneumococcal |
PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age) |
Ìý | Influenza | Annual flu vaccine |
Translations
Translated versions of the schedule are available to download as a PDF in:
Ìý, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and .
-
Intramuscular injection into deltoid muscle in upper arm or anterolateral aspect of the thigh.Ìý↩
-
Rotavirus vaccine should only be given after checking for a severe combined immunodeficiency (SCID) screening result.Ìý↩Ìý↩2Ìý↩3Ìý↩4
-
See annual flu letterÌý↩
-
If LAIV (live attenuated influenza vaccine) is contraindicated or otherwise unsuitable use inactivated flu vaccine (check Green Book chapter 19 for details).Ìý↩Ìý↩2
-
See Green Book HPV chapter 18a for details on immunising immunocompromised young people who will need 3 doses.Ìý↩
-
See Green Book shingles chapter 28a for details on eligible age groups including severely immunosuppressed individuals from age 50.Ìý↩Ìý↩2Ìý↩3Ìý↩4
-
Take blood for HBsAg at 12 months to exclude infection.Ìý↩
-
In addition hexavalent vaccine (Infanrix hexa or Vaxelis) is given at 8, 12 and 16 weeks.Ìý↩
-
Where the annual incidence of TB is >= 40/100,000 – see tuberculosis by country: rates per 100,000 peopleÌý↩
-
Ideally before 32 weeks gestation but may still be given after 32 weeks.Ìý↩
-
Check relevant chapter of the Green Book for specific scheduleÌý↩
-
If aged 2 years to under 10 years of age and unimmunised or partially immunised against pneumococcal infection, give one PCV13 dose.Ìý↩Ìý↩2Ìý↩3Ìý↩4Ìý↩5Ìý↩6Ìý↩7Ìý↩8Ìý↩9
-
Consider annual influenza vaccination for household members and those who care for people with these conditions.Ìý↩
-
To any age in severely immunocompromised.Ìý↩